Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human cell : official journal of Human Cell Research Society 2021-11, Vol.34 (6), p.1943-1944
Hauptverfasser:	Panda, Aditya K., Padhi, Sunali, Pati, Abhijit, Nayak, Tapan Kumar Singh
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Biomedical and Life Sciences Cell Biology Clinical trials COVID-19 COVID-19 - drug therapy Female Gynecology Humans Interleukin 6 Letter to the Editor Life Sciences Male Meta-Analysis as Topic Oncology Randomized Controlled Trials as Topic Receptors, Interleukin-6 - antagonists & inhibitors Reproductive Medicine Stem Cells Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!